UPMC Enterprise has returned for a $72m series B round raised by Werewolf Therapeutics, which is now set to advance two lead assets through phase 1 trials.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

CWRU‘s pain neurostimulation spinout has secured series BB funding ahead of a 180-patient trial.

Partners Healthcare-backed precision oncology drug developer Scorpion has now raised a total of $270m in funding in the past year.

Boston Scientific-backed pain cessation implant developer Neuros has secured $38m in a round co-led by Sectoral Asset Management and Amzak Health.

Leaps by Bayer led a round that also featured Amgen Ventures, Intel Capital and Alexandria Ventures Investments, taking the gene therapy technology developer's total funding to $158m.

The VR and AR technology developer, which was spun off by iQiyi, has closed an eight-figure series B round co-led by Yitang Changhou Fund and Fresh Capital.

UC-backed Congruent Ventures has contributed to a $55m round that will support the recycling robot maker's expansion plans.

GV and Sidewalk Infrastructure Partners contributed to a $55m round that will support the recycling robot maker's expansion plans.

The autonomous driving software provider completed a series B round led by BP Ventures that also featured corporate investors Tencent and Halma.